🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Outstanding event this week in Geneva, where the International Foundation for Research in #Paraplegia held a fundraiser featuring G Courtine and Bloch Jocelyne. Gert-Jan Oskam walked on stage and stood joyfully for hours during the cocktail party that followed. #empowered

Working with the top #neuroscience research universities across the globe, including Caltech, UCLA, EPFL, and @UOFL, @ONWARD has now built an #IP portfolio with over 300 issued or pending patents. Learn more here – ir.onwd.com/static-files/0… #ONWARD #Empowered #Neurostimulation

BBC News (UK) joined us in Switzerland few weeks ago to cover our next breakthrough - stay tuned! EPFL CHUV / Centre hospitalier universitaire vaudois bbc.com/news/av/scienc…

ONWARD Medical CEO Dave Marver, Professor G Courtine, and Dr. Bloch Jocelyne joined the Christopher & Dana Reeve Foundation and Nurse Linda to discuss epidural stimulation research and ONWARD’s role in translating this to therapies for people living with #SCI

We are pleased to announce ONWARD has obtained IP rights to develop innovations using Brain-Spine Interface technology that have the promise to further our therapies for mobility. Thanks to partners EPFL CHUV / Centre hospitalier universitaire vaudois NeuroRestore.swiss #braininterface #bci #sci #neurotech #medtech

Our preclinical platform for new advanced therapies is now out in Science Robotics. A great journey with my co-PI G Courtine and also with Stephanie P. Lacour and several EPFL Center for Neuroprosthetics and SantAnnaPisa scientists science.org/doi/10.1126/sc…

We’re pleased to announce the release of a new .NR publication into Science Robotics revue titled: Preclinical upper limb neurorobotic platform to assess, rehabilitate, and develop therapies. A collaboration between the ScuolaSupSant'Anna and the EPFL science.org/doi/10.1126/sc…

MSA leads to syncopes when standing. Our electronic implant prevents these drops in blood pressure, restoring walking. Read our latest article released today in NEJM ! CHUV / Centre hospitalier universitaire vaudois EPFL nejm.org/doi/full/10.10…

CEO Dave Marver will participate in the 21st #Needham Virtual Healthcare Conference, taking the floor this Monday, 11 April 2022 at 10:15 EDT – to share the plans to develop & commercialize our breakthrough therapies for people with #spinalcordinjury. #MedTech #financialnews #sci

Today we published our 2021 financial results and filed our first Annual Report as a listed company. We are proud of our 2021 full year financial & operating achievements. Read about highlights & access the Annual Report at ir.onwd.com #medtech #businessupdate #sci

Today ONWARD's ARC-IM IPG, the first neurostimulator designed for SCI, was implanted in a human for the first time by Dr. Bloch Jocelyne. This first-in-human implant was also the first enrollment in our HemON study to assess blood pressure and trunk control in people with #SCI.

#ONWARD is proud to announce completion of enrollment in LIFT Home, which studied the safety and performance of ARC-EX Therapy at home. Craig, Shepherd Center, Spaulding Rehab, UMN Medical School, University of Washington University of Washington. ir.onwd.com/static-files/8… @ONWDempowered #SCI

Promising findings from pre-clinical data published today in Nature Neuroscience show potential for ONWARD ARC-IM Therapy to help restore arm and hand function, key to the daily independence of people with #spinalcordinjury. Congrats to researchers University of Pittsburgh, EPFL, NeuroRestore.swiss.

It's ready! 🚀🚀🚀🚀🚀 Introducing Ellie - your email assistant! 💌 Ellie is powered by OpenAI and will learn your writing style and reply to emails as if you wrote them 🔥 If you want to be an early user, please retweet and comment below and I'll send you an invite code! 🙂

Today, the first-in-human implant of our investigational ARC-IM Lead was implanted by Jocelyne Bloch, MD, neurosurgeon at Centre Hospitalier Universitaire Vaudois in Lausanne, Switzerland, to benefit a patient with poor blood pressure regulation following spinal cord injury.

Congratulations to #RolexAwards Laureate Grégoire Courtine and his team for their article published in nature about a wireless digital bridge that transforms thought into action and allows a paralyzed person to walk again. More on bit.ly/gregoirecourti… #PerpetualPlanet

🧠⚡️🚶"Currently, Elon Musk has only implanted a chip in the brain. We have already linked our neurostimulation platform with (a brain-computer interface) device to restore movement after paralysis. We welcome the opportunity to do the same with the Neuralink device."

Congratulations to Jocelyne Bloch, neurosurgeon and prof. at EPFL/CHUV/UNIL, and G Courtine, prof. of neuroscience at EPFL/CHUV/UNIL, who have been named in the "Pioneers" category of the TIME100 Health list. Neuro-X Institute EPFL Life Sciences NeuroRestore.swiss TIME time.com/collection/tim…

⏰ We can't believe that #FENS2024 is already coming to an end! 🔬 What an enriching experience listening to the closing plenary lecture featuring speakers G Courtine and Jocelyne Bloch. Learn more: loom.ly/hSZjpsU

My management team is complete! I'm delighted to be able to count on the skills and leadership of Ambrogio Fasoli , F. Bommensatt, Edouard Bugnion 🇨🇭 and M. Gäumann, Stephanie P. Lacour , and M. Wannier from 1 January 2025. ETH-Rat go.epfl.ch/ab40c5